Regulatory Gap Analysis
HomeServicesDue DiligenceRegulatory Gap Analysis
Back to Due Diligence

Regulatory Gap Analysis

Finding the Flaws Before They Become Failures

Overview

Whether you are preparing for a submission or buying an asset, you need to know where the bodies are buried. Our gap analysis digs deep into the data, documentation, and strategy to identify compliance risks, missing data, and scientific weaknesses.

Key Features

Data integrity review
Compliance vs. Guideline assessment
Submission readiness check
Strategic alignment review

Our Process

1

Review

Systematic evaluation of the data room.

2

Identify

Flagging critical, major, and minor gaps.

3

Report

Delivering a detailed risk map.

Project Complete & Deliverables Provided

Frequently Asked Questions

A comprehensive gap analysis reviews all regulatory-relevant data: nonclinical studies (GLP compliance, study design), clinical trials (GCP compliance, protocol deviations, data integrity), CMC documentation (process validation, stability data, impurity profiles), regulatory submissions history, agency correspondence, and strategic alignment with current guidance. We look for missing data, outdated studies, and compliance issues.

Why Choose Us

  • Clear view of program risk
  • Prioritized remediation plan
  • Accurate valuation
  • Negotiation leverage

Get More Details

Request a personalized consultation and detailed information about this service.

Personalized consultation
Detailed service information
Custom timeline & proposal
Request Information

We'll respond within 24 hours

Ready to get started?

Contact our team to discuss your specific needs for Regulatory Gap Analysis.

Schedule Consultation

What Our Clients Say

"We thought we were 6 months from filing our NDA. Adelphi's gap analysis revealed critical stability data gaps and a process validation issue that would have resulted in a CRL. We fixed them before filing and received approval on the first cycle."

Dr. William Foster

VP Regulatory Affairs

Biotech Startup